NCT05534269View on ClinicalTrials.gov

Stress Urinary Incontinence Study to Assess Safety and Efficacy of Muvon's Muscle Precursor Cell Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 17, 2022

Primary Completion Date

July 14, 2025

Study Completion Date

July 14, 2025

Conditions
Female Stress Urinary Incontinence
Interventions
BIOLOGICAL

autologous muscle precursor cells

Patients own Muscle Precursor Cells are isolated and injected into the rhabdomyosphincter

Trial Locations (1)

8091

University Hospital Zurich, Zurich

All Listed Sponsors
collaborator

GCP-Service International Ltd. & Co. KG

INDUSTRY

lead

University of Zurich

OTHER